Renin suppression by saline is blunted in nonmodulating essential hypertension. 1987

S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
Department of Medicine, Harvard Medical School, Boston, Massachusetts.

We have reported that 50% of subjects with normal renin essential hypertension have both delayed suppression of the renin-angiotensin-aldosterone axis following sodium infusion and a delayed rate of excretion of an acute salt load. In another study we have also described a subset of patients with essential hypertension (called nonmodulators) who have several abnormalities, including a pressor response to salt loading. To evaluate whether the abnormalities described in these different groups of patients actually occur in the same patient, we assessed the renin-angiotensin-aldosterone axis response to short-term saline loading in 38 hypertensive patients. Their ability to modulate was determined by their renal vascular response to infused angiotensin II on a high salt diet (200 mEq Na). In response to a 3-hour infusion of saline, 75 mEq/hr, the reduction in plasma renin activity at both 60 and 120 minutes was significantly greater (p less than 0.008) in patients with normal modulation than in the nonmodulators. Plasma aldosterone levels were also significantly lower (p less than 0.001) in those with intact modulation. Thus, nonmodulating essential hypertensive patients have abnormalities in several systems that influence sodium homeostasis, including altered adrenal and renal vascular response to angiotensin II, altered renal blood flow response to salt loading, and a delayed suppression of the renin-angiotensin-aldosterone system with short-term saline infusion.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
September 1999, Hypertension (Dallas, Tex. : 1979),
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
January 1996, Ryoikibetsu shokogun shirizu,
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
July 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation,
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
April 1971, Arizona medicine,
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
September 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS,
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
December 2007, Journal of hypertension,
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
February 1990, American journal of hypertension,
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
April 1976, Clinical science and molecular medicine,
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
July 1976, Lancet (London, England),
S L Rabinowe, and J E Redgrave, and D M Shoback, and S Podolsky, and N K Hollenberg, and G H Williams
March 1975, Klinische Wochenschrift,
Copied contents to your clipboard!